AstraZeneca
AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Some of the key events about AstraZeneca
- 1913The company was founded as Astra AB in Södertälje, Sweden
- 1999Astra AB merged with Zeneca Group to form AstraZeneca
- 1999Paid $355 million to settle allegations of Medicare fraud
- 2003Faced criticism for allegedly suppressing negative clinical trial data for the antidepressant Seroquel
- 2004Launched Crestor, a highly effective cholesterol-lowering drug
- 2007Acquired MedImmune, expanding its biologics and vaccines capabilities
- 2010Paid $520 million to settle allegations of off-label marketing of the antipsychotic drug Seroquel
- 2011Received FDA approval for Brilinta, a blood-thinning medication for acute coronary syndromes
- 2011Agreed to pay $68.5 million to settle allegations of deceptive marketing practices for Seroquel
- 2013Faced accusations of bribing doctors in China to boost drug sales
- 2014Successfully fended off a takeover attempt by Pfizer, maintaining its independence
- 2014Paid $110 million to settle allegations of violating the Foreign Corrupt Practices Act in multiple countries
- 2015Acquired ZS Pharma, strengthening its cardiovascular and metabolic disease portfolio
- 2016Agreed to pay $5.5 million to resolve allegations of violating a previous corporate integrity agreement
- 2019Launched Calquence for the treatment of chronic lymphocytic leukemia
- 2020Developed a COVID-19 vaccine in collaboration with Oxford University
- 2020Faced criticism for delays and supply shortages in COVID-19 vaccine production for the European Union
- 2021Acquired Alexion Pharmaceuticals, expanding into rare disease treatments
- 2021Several European countries temporarily suspended use of AstraZeneca's COVID-19 vaccine due to blood clot concerns
- 2021Criticized for selling its stake in Moderna for $1 billion before the COVID-19 pandemic, missing out on larger gains
Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.